Navigation Links
CorNova Announces Addition of Andrew T. Jay, D.M.D., M.B.A., to its Board of Directors
Date:3/3/2009

BURLINGTON, Mass., Mar. 3 /PRNewswire/ -- CorNova, Inc. today announced the addition of Andrew T. Jay, D.M.D., to its board of directors. The addition increases board membership to 4.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070206/CLTU213LOGO )

Dr. Jay, 46, is the managing partner of the Medical Solutions Fund of Siemens Venture Capital GmbH, the venture organization for Siemens AG. Prior to joining Siemens Venture Capital, he was an Institutional Investor-ranked medical technology analyst with both Alex. Brown and Wachovia Securities, where his coverage included cardiovascular device companies. Dr. Jay received his D.M.D. from the University of Pennsylvania and his M.B.A. from the Kellogg School at Northwestern. He earned his B.S. from Rensselaer Polytechnic Institute.

"Adding such an accomplished and experienced venture investor and medical technology analyst to our board is an important step in the development of CorNova," said S. Eric Ryan, M.D., CorNova's chief executive officer. "His advice will be invaluable as our company advances our FiberHalo(TM) angioplasty catheter toward commercialization, and we move forward to CE-Mark approval for our Valecor Platinum(TM) Coronary Stent System."

"CorNova's FiberHalo catheter and Valecor Platinum Coronary Stent System address two separate billion dollar market opportunities with approaches that could sell well on their own or shift market share significantly in the hands of a major player in the cardiovascular space," said Dr. Jay. He is taking this role independent of his activity at Siemens Venture Capital.

About CorNova

CorNova is a developer of next-generation endovascular products designed to integrate new technologies into existing products and procedures, resulting in better patient outcomes without added procedure time, cost and patient risk. The company's FiberHalo(TM) stent deployment and post-dilatation angioplasty balloon catheters are designed to provide stent lumen area measurement within the angioplasty catheter itself. CorNova is also developing a pre-dilatation form of the FiberHalo catheter that can obtain information on an arterial plaque's composition, allowing for superior treatment selection, and the Valecor Platinum(TM) Coronary Stent, an advanced "bare-metal stent" with an ion-infused pure platinum surface that has shown superior performance and anti-restenosis properties compared to current bare-metal stents. For more information, visit www.cornova.com.


'/>"/>
SOURCE CorNova, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Marketing Technology Solutions Announces Strong 2008 Growth and Web Site Enhancements for QualityHealth.com
2. Genoptix Announces Participation at Barclays Capital Global Healthcare Conference
3. Marinus Pharmaceuticals, Inc. Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults With Partial Onset Seizures
4. Osteotech Announces Fourth Quarter and Full Year 2008 Earnings Release and Conference Call; Company to Release Financial Results on Wednesday, March 4, 2009 and Host Call on Thursday, March 5, 2009
5. WellPoint Announces Appearances at Upcoming Conferences
6. Align Technology Announces International Availability of Invisalign Teen(TM)
7. MHA Announces: Launch of New Website
8. National Instruments Announces New Suite of Prototyping Hardware to Lower Development Time and Costs
9. Lilly Announces Leadership Changes
10. Availity Announces Support of Project SwipeIT
11. The Vitality Group Announces Expansion to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th Annual ... Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised funds ... been wounded in battle and their families. Venture Construction Group is a 2016 Silver ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
Breaking Medicine Technology: